Evidence map›Paper›PMID 33706578›Full record

ArticleThe Journal of international medical research2021

Analysis of transcriptome in the relationship between expression of PRC1 protein and prognosis of patients with cholangiocarcinoma.

Qing Wang, Shaoqiong Lu, Ying Chen, Hua He, Weihui Lu, Kanru Lin

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Qing WangDepartment of Surgery, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China.
Shaoqiong LuDepartment of Surgery, Changning County People's Hospital, Baoshan, Yunnan, China.
Ying ChenDepartment of Surgery, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0001-8363-1024
Hua HeDepartment of Surgery, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China.
Weihui LuDepartment of Surgery, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China.
Kanru LinDepartment of Surgery, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China.
Fudan University · CNJingning County People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate whether protein regulator of cytokinesis 1 (

methodsData and tissues from patients with CCA were retrospectively studied. Immunohistochemical staining and western blotting were used to evaluate and contrast the

resultsA total of 45 patients were included.

conclusionsThe present results suggest that PRC1 may be a prognostic and therapeutic biomarker for patients with CCA.

Indexed as

Bile Duct NeoplasmsCell Cycle ProteinsCholangiocarcinomaBile Ducts, IntrahepaticCytokinesisHumansPrognosisRetrospective StudiesTranscriptomeCell Cycle ProteinsPRC1 protein, humanCCAPRC1prognosisProtein regulator of cytokinesis 1

Identifiers

PMID33706578
PMCPMC8165842
OpenAlexW3134300354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.